Test Price
2,800 AEDโ Home Collection Available
MECP2 Gene Angelman-Like Syndrome Genetic Test in UAE | AED 2,800 | DHA Licensed Laboratory
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed genetics consultant.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MECP2 Gene Angelman-Like Syndrome Genetic Test detects pathogenic variants in the MECP2 gene associated with an Angelman syndrome-like phenotype, offering a definitive molecular diagnosis for patients with unexplained neurodevelopmental delay, ataxia, and absent speech. This test analyses the full coding region through high-depth Next-Generation Sequencing (NGS) with orthogonal Sanger confirmation, ensuring the highest resolution for single-nucleotide variants and copy number changes.
| Feature | Our Test (MECP2 Angelman-Like NGS) | Closest Alternative (Single Gene Sanger) |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity | ~85% (limited to known hotspots) |
| Method | Next-Generation Sequencing (NGS) with Sanger confirmation | Sanger Sequencing only |
| Turnaround Time | 3 to 4 Weeks (comprehensive analysis) | 4 to 6 Weeks |
Physician Insight & Safety Protocols
"Families seeking answers for a child with unexplained neurodevelopmental regression and a suspected Angelman-like presentation carry a heavy emotional load. This MECP2 sequencing test delivers a precise molecular answer, yet the result must always be interpreted within the full clinical picture including neurological examination and family pedigree. Never modify a treatment regimen or initiate new therapy solely based on this genetic report without a comprehensive consultation with your managing clinician."
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
This genetic test serves as a diagnostic investigation, not a therapeutic protocol. All prescribed medications, including antiepileptic drugs and behavioural therapies, must be continued as directed by the treating physician. Abrupt discontinuation of any medication without medical guidance may lead to serious adverse events.
Exclusion Criteria & Emergency Red Flags
- Do not proceed with sample collection if the patient is experiencing an acute febrile illness or suspected sepsis; reschedule.
- If the patient has received a blood transfusion in the last 14 days, wait at least 3 weeks to avoid donor DNA contamination.
- Emergency Red Flags: If the child develops sudden loss of motor skills, intractable seizures, or severe autonomic instability, seek immediate emergency medical attentionโdo not wait for test results.
- Minors require written consent from a legal guardian as per Federal Decree-Law No. 4 of 2016 on Medical Liability; unaccompanied minors cannot be tested.
Patient FAQ & Clinical Guidance
1. What is the purpose of the MECP2 Angelman-like syndrome test, and how does it differ from a standard Angelman test?
This NGS-based test specifically sequences the entire MECP2 gene to identify mutations that cause an Angelman-like presentation, distinct from classical Angelman syndrome which is typically due to UBE3A gene abnormalities on chromosome 15. The test covers all coding exons and flanking intronic regions with deep coverage for mosaic variant detection.
2. What sample types are accepted, and is home collection available in the UAE?
We accept whole blood in EDTA, extracted DNA, or a single drop of whole blood on an FTA card. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available across all Emirates from 8 AM to 11 PM, ensuring specimen integrity from your residence to our ISO-accredited laboratory.
3. What is the clinical significance of a negative result?
A negative MECP2 NGS result does not rule out all genetic causes of Angelman-like syndrome. Further testing for UBE3A, CDKL5, or chromosomal microarray may be recommended by your neurologist or clinical geneticist to investigate alternative aetiologies such as imprinting defects or other single-gene disorders.
UAE Regulatory & Data Privacy Adherence
Your data is protected under UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic information is handled with strict confidentiality and stored on encrypted servers within the UAE. Results are released only to the ordering physician or the patient with verified identity, ensuring compliance with local health data governance standards.
Clinical & Logistical Metadata
| Test Name | MECP2 Gene Angelman-Like Syndrome Genetic Test (NGS with Sanger Confirmation) |
| Price (AED) | AED 2,800 |
| Turnaround Time | 3 to 4 Weeks (comprehensive analysis) |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available |
| Methodology Used | Next-Generation Sequencing (NGS) with orthogonal Sanger confirmation for all clinically significant variants |
| ICD-10-CM Code | Q93.5 |
| LOINC Code | 83491-7 |
| DHA Facility License & Laboratory Address Invariants | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians